BABEL Ventures is leading the charge in early-stage consumer biotech investments. As the first VC check in many of our portfolio companies, we’ve seen diverse successes, from companies going public to returns as high as 40x - a true testament to our bold ethos and unwavering belief in groundbreaking ideas.

Since our launch in 2017, we’ve remained steadfast in our commitment to empowering visionary entrepreneurs who are not only driving innovation but also shaping a more sustainable future.